Alan Boyd joins Taysha Gene Therapies’ independent scientific advisory board
Professor Alan Boyd has joined Taysha Gene Therapies’ newly formed independent scientific advisory board. Taysha Gene Therapies, Inc., a patient-centric gene therapy company focused on developing and commercialising AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations, has announced the formation of an independent Scientific […]
